Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,500.00    -150.00 (-3.23%)
Bid:
4,450.00
Ask:
4,550.00
Spread: 100.00 (2.247%)
Market Cap: £299.73m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Special dividend

21 Nov 2019 07:00

RNS Number : 1305U
Judges Scientific PLC
21 November 2019
 

21 November 2019

Judges Scientific plc

("Judges Scientific", "the Company", or "the Group")

Special dividend

 

The Board of Judges Scientific today announces that in order to prioritise the interests of its shareholders it has decided to pay a special dividend of £2.00 per ordinary share, totalling £12.4 million.

The Board has assessed the Group's cash resources, its robust cash generation and the Group's ability to borrow for acquisitions, which result from a sustained period of strong performance. The special dividend will absorb a modest proportion of the resources available to conduct acquisitions and the Board is therefore confident that this special dividend will not interfere with the execution of Judges' unchanged buy-and-build strategy.

Payment of the special dividend will be on Tuesday 10 December 2019 to shareholders on the register on Friday 29 November 2019. The shares will go ex-dividend on Thursday 28 November 2019. The special dividend will be funded from existing cash balances.

 

Alex Hambro, Chairman of Judges Scientific, commented: 

"The payment of this special dividend is a reflection of our constant focus on shareholders' interests. Following this payment, the Group will have returned to shareholders four and a half times the IPO price."

 

For further information please contact: 

 

Judges Scientific 

David Cicurel, CEO 

Brad Ormsby, Group FD 

Tel: +44 (0) 20 3829 6970 

 

Shore Capital (Nominated Adviser & Broker) 

Stephane Auton 

Edward Mansfield 

Tel: +44 (0) 20 7408 4090 

 

Liberum (Joint Broker)

Bidhi BhomaEuan Brown

Tel: +44 (0) 20 3100 2222

 

Media enquiries: 

Alma PR (Financial Public Relations) 

Rebecca Sanders-Hewett 

Sam Modlin 

 

Tel: +44 (0) 20 3405 0205

judges@almapr.co.uk 

 

Notes to editors: 

 

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses. The Group currently consists of 16 businesses acquired since it was re-admitted to AIM in 2005. 

 

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group companies hold five Queen's Awards for innovation and export.  

 

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins. 

 

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.  

 

For further information, please visit www.judges.uk.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DIVKMMZMLGNGLZM
Date   Source Headline
29th Sep 20142:49 pmRNSHolding(s) in Company
24th Sep 20147:00 amRNSHalf Yearly Report
16th Sep 20147:00 amRNSNotice of Results
10th Sep 20147:00 amRNSDirector/PDMR Shareholding
8th Aug 20142:29 pmRNSDirector/PDMR Shareholding
22nd Jul 20147:00 amRNSDirector/PDMR Shareholding
18th Jul 20143:14 pmRNSHolding(s) in Company
17th Jul 20147:00 amRNSTrading Statement
9th Jul 20145:24 pmRNSDirector/PDMR Shareholding
6th Jun 20143:52 pmRNSDirector/PDMR Shareholding
5th Jun 201412:03 pmRNSIssue of Equity
3rd Jun 20144:15 pmRNSDirector/PDMR Shareholding
23rd May 20143:20 pmRNSExercise of options
22nd May 20147:00 amRNSPayment of deferred consideration for Scientifica
19th May 20143:08 pmRNSExercise of options
12th May 20141:54 pmRNSDirector/PDMR Shareholding
24th Apr 20145:30 pmRNSExercise of Options
10th Apr 201412:01 pmRNSExercise of options
8th Apr 20146:15 pmRNSDirector/PDMR Shareholding
4th Apr 20142:28 pmRNSExercise of Options
28th Mar 20147:00 amRNSFinal Results
10th Mar 201410:00 amRNSNotice of Results
10th Mar 20148:51 amRNSDirector/PDMR Shareholding
7th Feb 20142:53 pmRNSDirector/PDMR Shareholding
24th Jan 20147:00 amRNSTrading Statement
22nd Jan 20142:01 pmRNSExercise of Options
13th Jan 20141:40 pmRNSHolding(s) in Company
10th Jan 20146:00 pmRNSHolding(s) in Company
9th Jan 20144:34 pmRNSDirector/PDMR Shareholding
13th Dec 201310:31 amRNSIssue of Equity
10th Dec 20138:39 amRNSDirector/PDMR Shareholding
4th Dec 20134:06 pmRNSIssue of Equity
26th Nov 20133:31 pmRNSDirector/PDMR Shareholding
20th Nov 20137:00 amRNSTrading Statement
7th Nov 20132:04 pmRNSDirector/PDMR Shareholding
25th Oct 20135:24 pmRNSHolding(s) in Company
25th Oct 20134:19 pmRNSDirector/PDMR Shareholding
21st Oct 20137:00 amRNSPlacing to raise GBP8.125 million
9th Oct 20131:25 pmRNSDirector/PDMR Shareholding
2nd Oct 20135:47 pmRNSHolding(s) in Company
26th Sep 20137:00 amRNSHalf Yearly Report
17th Sep 20134:17 pmRNSNotice of Results
9th Sep 20134:15 pmRNSDirector/PDMR Shareholding
13th Aug 201312:48 pmRNSHolding(s) in Company
6th Aug 20134:33 pmRNSDirector/PDMR Shareholding
18th Jul 20132:04 pmRNSDirector/PDMR Shareholding
18th Jul 20137:00 amRNSTrading Statement
15th Jul 20134:59 pmRNSExercise of Options
10th Jul 20131:27 pmRNSExercise of options
9th Jul 20137:00 amRNSDirector/PDMR Shareholding and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.